Treatment Archives – Page 10 of 11 – Treatment Action Group

TAG Responds to the Release of the World Health Organization’s 2016 Global Tuberculosis Report

October 13, 2016
Chad Cipiti

TB is a preventable, curable disease, and the dismal lack of progress against reversing the TB epidemic is unacceptable. Last year, the World Health Organization (WHO) reported that TB had overtaken HIV as the world's leading cause of death from an infectious disease, and this year the WHO numbers show that the TB epidemic is larger than previously estimated

Epclusa Fact Sheet

August 31, 2016
Chad Cipiti

Epclusa is a fixed-dose combination of two HCV-fighting drugs (sofosbuvir and velpatasvir) in one pill. In the United States, Epclusa is approved for people with all hepatitis C genotypes (1–6) who are 18 years of age and older.

Zepatier Fact Sheet

April 12, 2016
Chad Cipiti

Zepatier is two hepatitis C virus-fighting drugs in one tablet. These drugs block different steps of the virus lifecycle. In the United States, Zepatier is approved for people who are over 18 years old with hepatitis C genotype 1 or genotype 4.

Solvaldi Fact Sheet

April 2, 2016
Chad Cipiti

Sovaldi (sofosbuvir) is an HCV-fighting drug that must be used with other drugs. In the United States, Sovaldi is approved for people with hepatitis C genotypes 1, 2, 3, or 4 who are over 18 years old.

Daklinza Fact Sheet

April 2, 2016
Chad Cipiti

Daklinza (daclatasvir) is an HCV-fighting drug that blocks different steps of the virus life cycle. In the United States, Daklinza is approved for people over 18 years old who have HCV genotype 1 or genotype 3 (although it has been used in other genotypes).

Ribavirin Fact Sheet

December 2, 2015
Chad Cipiti

Ribavirin (RBV) is an HCV-fighting drug. RBV does not work by itself. Adding RBV to other drugs can increase the chance of being cured from HCV. In the United States, ribavirin is approved for children (3 to 18 years of age) and adults.

Adherence Fact Sheet

December 2, 2015
Chad Cipiti

What is adherence? Adherence means sticking to something. It is often used to describe taking medicine without missing doses for as long as needed. Good adherence helps to maintain—or improve—your health. This fact sheet is about adherence to hepatitis C…

Olysio Fact Sheet

December 2, 2015
Chad Cipiti

Olysio (simeprevir) is an HCV-fighting drug. It must be used with other drugs to treat hepatitis C. In the United States, Olysio is approved for people with hepatitis C genotype 1 who are over 18 years old.

Community Recommendations for Clinical Research Involving Antiretroviral Treatment Interruptions

July 29, 2014
Chad Cipiti

This brief review provides community recommendations for research that requires HIV-positive people to interrupt antiretroviral treatment (ART).

Story: Stem Cell Transplants for Cancers “Cleared” HIV in Two Australians

July 16, 2014
Dorrit Walsh

July 2014 Examples of media coverage: HIV “Cleared” in Two Australian Men after Bone-Marrow Transplants– Sydney Morning Herald, July 19, 2014 HIV Said Cleared in Two Bone Marrow Transplant Patients– Bloomberg News, July 18, 2014 Cancer Treatment Clears Two Australian Patients…